Active ingredientSorafenibCat. No. P-S066-001CAS 284461-73-0Family · Pharmaceutical analytical standards
Sorafenib
An oral multikinase inhibitor that slows both tumour growth and the blood vessels that feed it: approved in the US in 2005 for advanced kidney cancer and in 2007 for hepatocellular carcinoma. This family brings together the active ingredient, pharmacopoeial impurities, metabolites, labelled standards, nitrosamines and other impurities.
Did you know?It came from a search for biaryl ureas able to block the C-RAF kinase, a switch for cell growth, and turned out to hit the VEGFR receptors of blood vessels as well.
Go to the active ingredient →Active ingredientSorafenibCat. No. P-S066-001CAS 284461-73-0
Active ingredientSorafenib TosylateCat. No. P-S066-002CAS 475207-59-1
Pharmacopoeial impuritySorafenib EP Impurity ACat. No. P-S066-004CAS 284462-37-9
Pharmacopoeial impuritySorafenib EP Impurity CCat. No. P-S066-005CAS 320-51-4
Pharmacopoeial impuritySorafenib EP Impurity DCat. No. P-S066-006CAS 2206827-14-5
Pharmacopoeial impuritySorafenib EP Impurity ECat. No. P-S066-007CAS 284670-98-0
Pharmacopoeial impuritySorafenib EP Impurity FCat. No. P-S066-008CAS 1285533-84-7
Pharmacopoeial impuritySorafenib EP Impurity GCat. No. P-S066-009CAS 18585-06-3
Pharmacopoeial impuritySorafenib EP Impurity HCat. No. P-S066-010CAS 1431697-81-2
Pharmacopoeial impuritySorafenib EP Impurity JCat. No. P-S066-011CAS 2206827-18-9
MetaboliteSorafenib-beta-D-GlucuronideCat. No. P-S066-012CAS 1130164-93-0
Isotopically labelledSorafenib N-Oxide 13C-D3Cat. No. P-S066-013
Isotopically labelledSorafenib-d3Cat. No. P-S066-014CAS 1130115-44-4
Isotopically labelledSorafenib-d4Cat. No. P-S066-015CAS 1207560-07-3
NitrosamineN1-Nitroso SorafenibCat. No. P-S066-016
NitrosamineN2-Nitroso SorafenibCat. No. P-S066-017
NitrosamineN3-Nitroso SorafenibCat. No. P-S066-018
ImpuritySorafenib Impurity 1Cat. No. P-S066-019CAS 343247-69-8
ImpuritySorafenib Impurity 2Cat. No. P-S066-020CAS 1129683-83-5
ImpuritySorafenib Impurity 3Cat. No. P-S066-021CAS 88330-63-6
Impurity2-chloro-5-nitro benzo trifluorideCat. No. P-S066-022CAS 777-37-7
ImpuritySorafenib Impurity 4Cat. No. P-S066-023CAS 1256817-30-7
Impurity3-(Trifluoromethyl)phenyl isocyanateCat. No. P-S066-024CAS 329-01-1
ImpuritySorafenib Impurity 5Cat. No. P-S066-025CAS 284462-89-1
Impurity4-(2-aminophenoxy)-N-methylpicolinamideCat. No. P-S066-026CAS 1153328-25-6
Impurity4-(4-Aminophenoxy)picolinic acidCat. No. P-S066-027CAS 1012058-77-3
ImpuritySorafenib Impurity 6Cat. No. P-S066-028CAS 952490-71-0
Impurity4-(Hydroxyamino)phenolCat. No. P-S066-029CAS 3505-87-1
Pharmacopoeial impuritySorafenib EP Impurity BCat. No. P-S066-030CAS 2004659-84-9
Impurity4-chloro-N-methylpicolinamideCat. No. P-S066-031CAS 220000-87-3
ImpuritySorafenib Impurity 7Cat. No. P-S066-032CAS 1261456-08-9
Impurity6-Chloro-N-methylpyridine-2-carboxamideCat. No. P-S066-033CAS 845306-04-9
ImpurityFlucofuronCat. No. P-S066-034CAS 370-50-3
ImpuritySorafenib Impurity 8Cat. No. P-S066-035CAS 19448-54-5
ImpurityN-Desmethyl sorafenibCat. No. P-S066-036CAS 284461-74-1
ImpurityN-Desmethyl Sorafenib (Pyridine)-N-oxideCat. No. P-S066-037CAS 583840-04-4
ImpurityN-methyl-4-(4-ureidophenoxy)picolinamideCat. No. P-S066-038CAS 1129683-88-0
ImpuritySorafenib Impurity 9Cat. No. P-S066-039CAS 871555-75-8
Active ingredientSorafenib Hemi-TosylateCat. No. P-S066-040CAS 2056030-06-7
ImpuritySorafenib Impurity 10Cat. No. P-S066-041
ImpuritySorafenib Impurity 11Cat. No. P-S066-042CAS 1290546-48-3
ImpuritySorafenib Impurity 12Cat. No. P-S066-043
ImpuritySorafenib Impurity 13Cat. No. P-S066-044CAS 284461-82-1
ImpuritySorafenib Impurity 14Cat. No. P-S066-045
ImpuritySorafenib Impurity 15Cat. No. P-S066-046
ImpuritySorafenib Impurity 16Cat. No. P-S066-047
ImpuritySorafenib Impurity 17Cat. No. P-S066-048
ImpuritySorafenib Impurity 18Cat. No. P-S066-049CAS 862875-16-9
ImpuritySorafenib Urea Dimer Methyl EsterCat. No. P-S066-050CAS 2204442-52-2
ImpuritySorafenib N-OxideCat. No. P-S066-051CAS 583840-03-3
ImpuritySorafenib Impurity 19Cat. No. P-S066-052
ImpuritySorafenib Impurity 20Cat. No. P-S066-053
ImpuritySorafenib Impurity 21Cat. No. P-S066-054CAS 1012058-78-4
ImpuritySorafenib Impurity 22Cat. No. P-S066-055CAS 2004659-83-8
ImpuritySorafenib Impurity 23Cat. No. P-S066-056
ImpuritySorafenib Impurity 24Cat. No. P-S066-057
ImpuritySorafenib Impurity 25 HydrochlorideCat. No. P-S066-058
ImpuritySorafenib Impurity 26 HydrochlorideCat. No. P-S066-059
ImpuritySorafenib Impurity 27Cat. No. P-S066-060
ImpuritySorafenib Impurity 29Cat. No. P-S066-062No product matches your search.
EDQM standards 4
The official European Pharmacopoeia standards for this family.
Reference substanceSorafenib CRSEDQM code Y0002098Family SorafenibReference substanceSorafenib tosilate CRSEDQM code Y0002224Family SorafenibNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.